This announcement is a separate document:
双鹭药业：北京双鹭药业股份有限公司关于公司第二大股东减持计划数量过半的进展公告
Shuanglu Pharmaceutical: Beijing Shuanglu Pharmaceutical Co., Ltd.'s announcement on the progress of more than half of the holdings reduction plans of the company's second largest shareholder
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.